Research & Grants

Funding Opportunities - Women's Health

Innovative Research to Improve the Lives of Women with Diabetes Across the Lifespan

ADA Women's Health and Diabetes Research Awards RFA

ADA is soliciting proposals for research to better understand clinically important sex and gender differences to optimally inform prevention, diagnosis and treatment strategies for women across the lifespan and the development of sex-specific clinical guidelines where warranted. While this call is broad in scope and encompasses basic through clinical research, significant emphasis will be placed on diabetes clinical research and translation.


IMPORTANT TIMELINES

AWARD TYPEOPEN DATESUBMISSION DEADLINE
(5PM ET)		EARLIEST AWARD START DATE
DEVELOPMENT
Junior Faculty

- Letter of Interest (LOI):  October 3, 2023

- Invitation to Apply from ADA: December 20, 2023

- LOI: November 30, 2023

- Application: February 1, 2024

July 1, 2024
RESEARCH
Innovative Clinical or Translational Science

- Letter of Interest (LOI): October 3, 2023

- Invitation to Apply from ADA: December 20, 2023

- LOI: November 30, 2023

- Application: February 1, 2024

July 1, 2024
Innovative Basic Science

- Letter of Interest (LOI): October 3, 2023

- Invitation to Apply from ADA: December 20, 2023

- LOI: November 30, 2023

- Application: February 1, 2024

July 1, 2024

Development Awards

Award Summary

Description: These awards support early investigators as they establish independence as diabetes researchers. Refer to the RFA for further details.

Award Term: Up to 3 years
Applicant: Any level faculty up to & including Assistant Prof or equivalent, ≤10 years research experience beyond terminal degree
Maximum Funding: $138,000/year, plus optional student loan repayment ($10K/year)
Support: Project support & PI salary up to $75K (excluding fringe)
Indirect Support: Up to 10% of directs
Citizenship: Authorized to work in U.S. or U.S. possessions
Deadline: FEBRUARY 1, 2024

Application Materials:

 

Research Awards

Award Summary

Description: These awards support research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples and/or data, and offer considerable promise for advancing the cure, prevention or treatment. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Refer to the RFA for further details.

Award Term: Up to 3 years
Applicant: Any level faculty
Maximum Funding: $200,000/year
Support: Project support and PI salary up to 20% of total costs
Indirect Support: Up to 10% of directs
Citizenship: Authorized to work in U.S. or U.S. possessions
Deadline: FEBRUARY 1, 2024

Application Materials:

Award Summary

Description: These awards support basic research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that holds significant promise for advancing the prevention, cure or treatment of diabetes. Applications proposing high-risk projects with the potential for high-impact results are encouraged, as are studies that may not be sufficiently developed for traditional funding sources. Refer to the RFA for further details.

Award Term: Up to 3 years
Faculty Position: Any level faculty
Support: Awards provide up to $115,000 per year for up to three years, including indirect costs. Up to 20% of total costs may be requested for PI salary support.
Indirect Support: Up to 10% of direct costs.
Citizenship: Applicants must be authorized to work in the United States or U.S. possessions.
Deadline: FEBRUARY 1, 2024

Application Materials:

Other Forms

Questions?

Please contact Research Programs staff at grantquestions@diabetes.org.